AIF1 and Alzheimer disease: Individuals with unusually high levels of Aβ and/or neurofibrillary tangles do not necessarily suffer from cognitive decline or neuronal loss, and these resilient cases differ from AD patients in that they exhibit a reduced level of glial activation markers GFAP and Iba-1 [21], thus suggesting a role for the brain’s immune system in AD.